Haverford Trust Company’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.21M Hold
3,115
0.01% 215
2025
Q1
$1.35M Sell
3,115
-153
-5% -$66.5K 0.01% 202
2024
Q4
$1.21M Sell
3,268
-22
-0.7% -$8.12K 0.01% 206
2024
Q3
$1.71M Buy
3,290
+13
+0.4% +$6.76K 0.02% 185
2024
Q2
$1.78M Sell
3,277
-95
-3% -$51.5K 0.02% 182
2024
Q1
$1.75M Sell
3,372
-22
-0.6% -$11.4K 0.02% 182
2023
Q4
$1.6M Buy
3,394
+35
+1% +$16.5K 0.02% 178
2023
Q3
$1.46M Hold
3,359
0.02% 175
2023
Q2
$1.49M Sell
3,359
-39
-1% -$17.3K 0.02% 175
2023
Q1
$1.56M Buy
3,398
+190
+6% +$87.4K 0.02% 162
2022
Q4
$1.65M Sell
3,208
-470
-13% -$241K 0.02% 154
2022
Q3
$1.67M Sell
3,678
-98
-3% -$44.5K 0.02% 149
2022
Q2
$1.82M Buy
3,776
+150
+4% +$72.4K 0.02% 152
2022
Q1
$1.78M Sell
3,626
-120
-3% -$58.9K 0.02% 155
2021
Q4
$1.74M Sell
3,746
-625
-14% -$290K 0.02% 160
2021
Q3
$1.63M Sell
4,371
-91
-2% -$33.9K 0.02% 161
2021
Q2
$1.7M Buy
4,462
+297
+7% +$113K 0.02% 162
2021
Q1
$1.5M Hold
4,165
0.02% 157
2020
Q4
$1.34M Buy
4,165
+395
+10% +$127K 0.02% 145
2020
Q3
$1.01M Hold
3,770
0.02% 160
2020
Q2
$991K Sell
3,770
-2
-0.1% -$526 0.02% 155
2020
Q1
$856K Sell
3,772
-60
-2% -$13.6K 0.02% 158
2019
Q4
$1.16M Buy
3,832
+2,069
+117% +$625K 0.02% 161
2019
Q3
$423K Buy
1,763
+33
+2% +$7.92K 0.01% 223
2019
Q2
$488K Buy
1,730
+101
+6% +$28.5K 0.01% 211
2019
Q1
$467K Sell
1,629
-175
-10% -$50.2K 0.01% 213
2018
Q4
$474K Sell
1,804
-285
-14% -$74.9K 0.01% 206
2018
Q3
$572K Hold
2,089
0.01% 197
2018
Q2
$497K Sell
2,089
-151
-7% -$35.9K 0.01% 207
2018
Q1
$492K Buy
2,240
+515
+30% +$113K 0.01% 202
2017
Q4
$388K Buy
1,725
+615
+55% +$138K 0.01% 215
2017
Q3
$211K Hold
1,110
﹤0.01% 260
2017
Q2
$209K Buy
+1,110
New +$209K ﹤0.01% 250